These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cerebrospinal fluid concentrations of folate, biogenic amines and pterins in Rett syndrome: treatment with folinic acid. Ormazabal A; Artuch R; Vilaseca MA; Aracil A; Pineda M Neuropediatrics; 2005 Dec; 36(6):380-5. PubMed ID: 16429378 [TBL] [Abstract][Full Text] [Related]
23. Lamotrigine in Rett syndrome. Uldall P; Hansen FJ; Tonnby B Neuropediatrics; 1993 Dec; 24(6):339-40. PubMed ID: 8133981 [TBL] [Abstract][Full Text] [Related]
24. Amino acids and transaminases activity in ventricular CSF and in brain of normal and Alzheimer patients. D'Aniello A; Fisher G; Migliaccio N; Cammisa G; D'Aniello E; Spinelli P Neurosci Lett; 2005 Nov; 388(1):49-53. PubMed ID: 16039064 [TBL] [Abstract][Full Text] [Related]
25. In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses. Fiszman ML; Ricart KC; Latini A; Rodríguez G; Sica RE Acta Neurol Scand; 2010 Feb; 121(2):120-6. PubMed ID: 19804473 [TBL] [Abstract][Full Text] [Related]
26. [Rett syndrome. A report of fifteen cases]. Echenne B; Bressot N; Cheminal R; Van Leuwen F; Compagnon P; Azaïs M Ann Pediatr (Paris); 1989 Dec; 36(10):661-8. PubMed ID: 2533856 [TBL] [Abstract][Full Text] [Related]
27. [Detection of amino acid neurotransmitters in cerebrospinal fluid of patients in persistent vegetative state]. Guo YW; Xu RX Di Yi Jun Yi Da Xue Xue Bao; 2005 Jan; 25(1):71-4. PubMed ID: 15684002 [TBL] [Abstract][Full Text] [Related]
28. Determination of delta-aminobutyric acid and other amino acids in cerebrospinal fluid of pediatric patients by reversed-phase liquid chromatography. Goldsmith RF; Earl JW; Cunningham AM Clin Chem; 1987 Oct; 33(10):1736-40. PubMed ID: 2889543 [TBL] [Abstract][Full Text] [Related]
29. Elevated concentrations of glutamate and aspartate in human ventricular cerebrospinal fluid (vCSF) during episodes of increased CSF pressure and clinical signs of impaired brain circulation. Engelsen BA; Fosse VM; Myrseth E; Fonnum F Neurosci Lett; 1985 Nov; 62(1):97-102. PubMed ID: 2866476 [TBL] [Abstract][Full Text] [Related]
30. Inhibitory and excitatory amino acids in cerebrospinal fluid of neurolathyrism patients, a highly prevalent motorneurone disease. Khan JK; Kuo YH; Haque A; Lambein F Acta Neurol Scand; 1995 Jun; 91(6):506-10. PubMed ID: 7572048 [TBL] [Abstract][Full Text] [Related]
35. Folate receptor autoantibodies and spinal fluid 5-methyltetrahydrofolate deficiency in Rett syndrome. Ramaekers VT; Sequeira JM; Artuch R; Blau N; Temudo T; Ormazabal A; Pineda M; Aracil A; Roelens F; Laccone F; Quadros EV Neuropediatrics; 2007 Aug; 38(4):179-83. PubMed ID: 18058624 [TBL] [Abstract][Full Text] [Related]
36. Folinic acid supplementation in Rett syndrome patients does not influence the course of the disease: a randomized study. Hagebeuk EE; Duran M; Koelman JH; Abeling NG; Vyth A; Poll-The BT J Child Neurol; 2012 Mar; 27(3):304-9. PubMed ID: 21868372 [TBL] [Abstract][Full Text] [Related]
37. Effect of different sample pretreatment methods on the concentrations of excitatory amino acids in cerebrospinal fluid determined by high-performance liquid chromatography. Zhang H; Zhai SD; Li YM; Chen LR J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 784(1):131-5. PubMed ID: 12504191 [TBL] [Abstract][Full Text] [Related]
38. Decreased cerebrospinal fluid levels of substance P in patients with Rett syndrome. Matsuishi T; Nagamitsu S; Yamashita Y; Murakami Y; Kimura A; Sakai T; Shoji H; Kato H; Percy AK Ann Neurol; 1997 Dec; 42(6):978-81. PubMed ID: 9403492 [TBL] [Abstract][Full Text] [Related]